Cargando…

An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1

This paper describes a single site, open-label Phase I clinical trial evaluating the safety, tolerability and immunogenicity in healthy volunteers of a herpes simplex polynucleotide vaccine that has previously been shown to enhance immunogenicity and protect against lethal herpes simplex virus type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dutton, Julie L., Woo, Wai-Ping, Chandra, Janin, Xu, Yan, Li, Bo, Finlayson, Neil, Griffin, Paul, Frazer, Ian H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215501/ https://www.ncbi.nlm.nih.gov/pubmed/27580249 http://dx.doi.org/10.1080/21645515.2016.1221872

Ejemplares similares

Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial
por: Chandra, Janin, et al.
Publicado: (2019)

A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice
por: Dutton, Julie L., et al.
Publicado: (2013)

DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection
por: Chandra, Janin, et al.
Publicado: (2017)

Structure of the herpes simplex virus portal-vertex
por: McElwee, Marion, et al.
Publicado: (2018)

A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis
por: Uyar, Olus, et al.
Publicado: (2021)

Herpes Simplex Virus 2 ICP0(−) Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine
por: Halford, William P., et al.
Publicado: (2010)

First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers
por: Blank, Antje, et al.
Publicado: (2022)

Herpes Simplex and Pseudorabies Viruses
por: Hierholzer, Walter J.
Publicado: (1970)

Treatment of Herpes Simplex Encephalitis
por: Illis, L. S., et al.
Publicado: (1972)

Fulminating herpes simplex hepatitis
por: Ahmed, Raheel, et al.
Publicado: (2022)

The interaction of Herpes Simplex Virus with murine lymphocytes. I. Mitogenic properties of herpes simplex virus
Publicado: (1977)

Attenuated Phenotype and Immunogenic Characteristics of a Mutated Herpes Simplex Virus 1 Strain in the Rhesus Macaque
por: Fan, Shengtao, et al.
Publicado: (2018)

CXCL11 production in cerebrospinal fluid distinguishes herpes simplex meningitis from herpes simplex encephalitis
por: Lind, Liza, et al.
Publicado: (2017)

Entry Pathways of Herpes Simplex Virus Type 1 into Human Keratinocytes Are Dynamin- and Cholesterol-Dependent
por: Rahn, Elena, et al.
Publicado: (2011)

Safety and tolerability of escalating cannabinoid doses in healthy cats
por: Kulpa, Justyna E, et al.
Publicado: (2021)

Zosteriform herpes simplex and herpes zoster: A clinical clue
por: Aithal, Sanath, et al.
Publicado: (2013)

Herpes simplex and herpes zoster viruses in COVID-19 patients
por: Katz, Joseph, et al.
Publicado: (2021)

Herpes simplex esophagitis in an immunocompetent host: a case report
por: Upadhaya Regmi, Binit, et al.
Publicado: (2021)

Celiac Crisis Associated with Herpes Simplex Virus Esophagitis
por: Chen, Alan, et al.
Publicado: (2016)

PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis
por: He, Yun, et al.
Publicado: (2022)

Herpes Simplex Virus Infection in Pregnancy
por: Straface, Gianluca, et al.
Publicado: (2012)

Normocellular CSF in herpes simplex encephalitis
por: Saraya, Abhinbhen W., et al.
Publicado: (2016)

Autoimmune Post-Herpes Simplex Encephalitis
por: Chelse, Ana B., et al.
Publicado: (2016)

Photodynamic Inactivation of Herpes Simplex Viruses
por: Monjo, Andrea L.-A., et al.
Publicado: (2018)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Patient priorities in herpes simplex keratitis
por: Liu, Xiaoxuan, et al.
Publicado: (2019)

Palate herpes simplex virus infection
por: Mosaico, Giovanna, et al.
Publicado: (2020)

Herpes simplex infection of the eye: an introduction
por: Bagga, Bhupesh, et al.
Publicado: (2020)

Developments in Vaccination for Herpes Simplex Virus
por: Krishnan, Rohini, et al.
Publicado: (2021)

Pathogenesis and virulence of herpes simplex virus
por: Zhu, Shuyong, et al.
Publicado: (2021)

A Tail-like Assembly at the Portal Vertex in Intact Herpes Simplex Type-1 Virions
por: Schmid, Michael F., et al.
Publicado: (2012)

Tinea Incognito Simulating Herpes Simplex Virus Infection
por: Park, Young Woon, et al.
Publicado: (2014)

Immunotherapy for HPV associated cancer
por: Frazer, Ian H., et al.
Publicado: (2019)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()
por: Waters, Alicia M., et al.
Publicado: (2016)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

Herpes simplex in oral ulcers in neutropenic patients.
por: Janmohamed, R., et al.
Publicado: (1990)

THE INACTIVATION OF HERPES SIMPLEX VIRUS BY PHOSPHATASE ENZYMES
por: Amos, Harold
Publicado: (1953)

Herpes Simplex Ulcerative Esophagitis in Healthy Children
por: Al-Hussaini, Abdulrahman A., et al.
Publicado: (2011)

Disseminated mucocutaneous herpes simplex in an atopic individual
por: Wilde, C, et al.
Publicado: (2011)

An Unusual Presentation of Herpes Simplex Virus Encephalitis
por: Boyapati, Ray, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0058mvk0nd9to039v13b5j8ouc